We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
What is Respiratory syncytial virus (RSV)
Respiratory syncytial virus (RSV)is a common cause of coughs and colds. It usually gets better by itself, but it can be serious for some babies and older adults.
A new vaccine is available from September 2024 for Respiratory Syncytial Virus (RSV).
Eligibility for the RSV vaccine
- Everyone turning 75 years old on or after 1st September 2024.
- For the first year of the programme, the vaccine is also being offered to those already aged 75 to 79 on 1st September 2024 as part of a national catch-up programme.
- Patients will primarily be invited by either SMS text message or email, (similar to flu and covid clinics). For those without this technology, letters or phone calls will be made to offer an appointment.
Published: Oct 21, 2024